Lantheus Holdings, Inc. (LNTH) · Oct 22, 2026 · Acquisition

Lantheus merger faces FTC second request, risking 2027 closing

FTC Second Request — HSR waiting period extends until 30 days after substantial compliance

Lantheus’ merger with Curium now faces an FTC Second Request, extending regulatory review and adding uncertainty to the planned first-half 2027 close.

Lantheus is a radiopharmaceutical company pursuing a combination with Curium that would pair Lantheus’ U.S. diagnostic business with Curium’s broader manufacturing and therapeutic platform. The merger has moved from routine clearance into deeper antitrust review. The FTC’s Second Request requires both parties to provide additional information and documents, rather than allowing the initial waiting period to expire. 〔0〕

This is a delay and execution risk, not a deal termination. The filing says the HSR waiting period now runs until 30 days after both sides substantially comply, unless the FTC ends it sooner. 〔1〕 That makes the previously stated first-half 2027 closing target less certain, while leaving the transaction formally intact.

The headline timing has not changed, but the path to closing is now more demanding. Management continues to expect completion in the first half of 2027, 〔2〕 but that timetable now depends on a more extensive FTC review and prompt, satisfactory responses from both parties.

Bottom line: The merger remains alive, but the FTC’s deeper review makes the closing timeline less predictable and adds a meaningful regulatory hurdle to an already announced transaction.

What to watch next

FTC clearance or further action after Second Request compliance

Original filing on SEC EDGAR

More Lantheus Holdings, Inc. news

Lantheus merger faces FTC second request, risking 2027 closing | LNTH Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.